ISLET Logo

Scientific Agenda

Key scientific highlights and session themes for ISLET 2026. A comprehensive program designed for excellence in cardiometabolic care.

Diabetes, Obesity & Metabolic Disease

  • Bone Health in Diabetes Mellitus
  • TZDs – Beyond Insulin Resistance and Cardiovascular Risks
  • Standards of Care in Overweight and Obesity
  • Approach to Diabetes Management in Rural Settings
  • Alzheimer's and Diabetes – Forgotten Link
  • Diabetes and Pollution – Unholy Link
  • Diagnostic Dilemma in Diagnosis of Diabetes (Other than Type 2)
  • Skeletal Muscle Dysfunction in Metabolic Disease – Indian Perspective
  • Personalized Nutrition in Obesity Management
  • Medical Nutrition Therapy in Type 2 Diabetes
  • Neurophysiological Mechanisms Underlying Obesity
  • Success Story of Type 1 Diabetes Management – 3 Decades Experience
  • Glycemic Variability Control in Indian Patients
  • Advancing Obesity Management with Semaglutide

Cardiovascular & Cardiometabolic Risk

  • Addressing Residual Cardiovascular Risk in Diabetes
  • Hypertension in Diabetes: Optimizing Combination Therapy
  • Managing Dyslipidemia in High-Risk Diabetic Patients
  • Residual Cardiovascular Risk in Diabetes – What Are We Missing?
  • Role of Lp(a) in Health and Disease
  • Women ASCVD Risk – How Different from Men?
  • Drug Revolution in Cardio-Diabetic Heart Failure
  • ASCVD Risk Stratification in Busy OPD
  • Emerging Biomarkers in Cardiometabolic Risk Assessment

Neuropathy, Kidney, and Complications

  • Neuropathy Beyond Pain – What Clinicians Should Know
  • Diabetic Neuropathy – Early Identification and Care
  • Early Predictors of Diabetic Kidney Disease
  • Diabetic Foot Assessment
  • Role of Hyperbaric Oxygen in Diabetic Foot
  • Diabetic Cystopathy – Diabetologist's Perspective

Obesity & Body Composition

  • Sarcopenic Obesity: Cardiometabolic Risk Factor
  • Sarcopenic Obesity Management
  • Weight Management After Weight Loss Drug Therapy
  • BMI vs Waist-Hip Ratio vs Body Composition

Liver, Inflammation & Metabolism

  • Comprehensive Approach to MASLD in Diabetes
  • Metabolic Dysfunction in Liver – Newer Insights
  • Inflammation and Insulin Resistance
  • Importance of Gut–Glucose Axis in Diabetes

Diabetes Treatment Advances & Drugs

  • Revisiting Pioglitazone: Strategic Combination
  • Continuous Glucose Monitoring in T2DM
  • Tirzepatide in Type 2 Diabetes
  • Tirzepatide Cardiometabolic Benefits
  • Tirzepatide and Weight Reduction
  • Beta-Cell Preservation Strategies in Type 2 Diabetes
  • Revisiting Combination Injectable Therapy in Advanced T2DM
  • Pharmacologic Interventions to Mitigate Insulin Resistance
  • Metformin – Still First Line Therapy?
  • Triple Drug Fixed Dose Combination
  • Personalized Therapy in Type 2 Diabetes

Diagnostics & Clinical Practice

  • Importance of Urine Routine Examination
  • Underrated UACR – Role in Clinical Practice
  • ECG Based Interesting Cases in Diabetes
  • Clinical Inertia in Diabetes Care
  • Setting up a Metabolic Clinic
  • Artificial Intelligence in Diabetes Management

Special Populations & Situations

  • Management of Diabetes in Young
  • Peripartum Management of Diabetes
  • Management of Nocturnal Hypoglycemia
  • Adult Immunisation in Diabetes

Thyroid, Anemia, Hormones & Related Disorders

  • Thyroid Disorders – Case-Based Approach
  • Anaemia in Chronic Conditions & Role of Ferric Maltol
  • Learning About Libido Management in Diabetes

Lifestyle, Holistic & Miscellaneous Topics

  • Circadian Rhythm and Disease Burden
  • Reversing Diabetes – Myth or Reality
  • Holistic Management of Diabetes
  • Comprehensive View to Improving Healthcare
  • Role of Laughter Medicine in OPD
  • Ancient Medicine in Modern Medicine – Myth or Reality